Use of tylvalosin as antiviral agent
US9066964B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 13, 2007 |
| Grant date | Jun 30, 2015 |
| Priority date | — |
| Expiry date | Dec 31, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a macrolide antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.